Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is filed by Nanobiotix S.A., a foreign private issuer headquartered in Paris, France, for the month of March 2026. The filing, dated March 12, 2026, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a standalone financial statement.
Material Changes
The filing text does not disclose specific material changes versus prior periods. The content is limited to the announcement of the press release attached as Exhibit 99.1.
Guidance, Outlook, and Risks
Specific guidance, management commentary, risks, contingencies, or unusual items are not detailed within the body of this Form 6-K. These details are contained within the referenced press release (Exhibit 99.1), the text of which is not included in the provided input.
Key Facts for Investor Verification
- Verify the full content of the press release dated March 12, 2026, attached as Exhibit 99.1, as the Form 6-K itself contains no operational or financial data.
- Confirm the identity of the signatory, Bart Van Rhijn, Chief Financial Officer, who authorized the report.
- Note that the filing date is March 12, 2026, indicating a forward-looking or future-dated scenario relative to current real-time data.